Literature DB >> 18089778

Caspase-8 interacts with the p85 subunit of phosphatidylinositol 3-kinase to regulate cell adhesion and motility.

Jamie Senft1, Brooke Helfer, Steven M Frisch.   

Abstract

Cell migration plays an important role in tumor cell invasion and metastasis. Previously, we reported that caspase-8 contributes to cell migration and adhesion, a novel nonapoptotic function of an established apoptotic factor. Herein, we report that pro-caspase-8 is capable of restoring cell migration/adhesion to caspase-8-null cells, establishing the first biological function of a pro-caspase. The catalytic activity of caspase-8 was not required for cell motility. Stimulation of motility with epidermal growth factor induced the phosphorylation of caspase-8 on tyrosine-380 and the interaction of caspase-8 with the p85 alpha subunit of phosphatidylinositol 3-kinase. Tyrosine-380 was required for the restoration of cell motility and cell adhesion in caspase-8-null cells, demonstrating the importance of the caspase-8-p85 interaction for these nonapoptotic functions. These results suggest that caspase-8 phosphorylation converts it from a proapoptotic factor to a cell motility factor that, through tyrosine-380, interacts with p85, an established cell migration component.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18089778     DOI: 10.1158/0008-5472.CAN-07-5755

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  45 in total

1.  Cross-talk between receptor tyrosine kinase and tumor necrosis factor-α signaling networks regulates apoptosis but not proliferation.

Authors:  Elsa M Beyer; Gavin MacBeath
Journal:  Mol Cell Proteomics       Date:  2012-02-08       Impact factor: 5.911

Review 2.  The regulatory crosstalk between kinases and proteases in cancer.

Authors:  Carlos López-Otín; Tony Hunter
Journal:  Nat Rev Cancer       Date:  2010-03-19       Impact factor: 60.716

3.  Oncogenic Ras and B-Raf proteins positively regulate death receptor 5 expression through co-activation of ERK and JNK signaling.

Authors:  You-Take Oh; Ping Yue; Wei Zhou; Justin M Balko; Esther P Black; Taofeek K Owonikoko; Fadlo R Khuri; Shi-Yong Sun
Journal:  J Biol Chem       Date:  2011-11-07       Impact factor: 5.157

4.  hnRNP L regulates the tumorigenic capacity of lung cancer xenografts in mice via caspase-9 pre-mRNA processing.

Authors:  Rachel Wilson Goehe; Jacqueline C Shultz; Charuta Murudkar; Sanja Usanovic; Nadia F Lamour; Davis H Massey; Lian Zhang; D Ross Camidge; Jerry W Shay; John D Minna; Charles E Chalfant
Journal:  J Clin Invest       Date:  2010-10-25       Impact factor: 14.808

Review 5.  Cellular mechanisms controlling caspase activation and function.

Authors:  Amanda B Parrish; Christopher D Freel; Sally Kornbluth
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-06-01       Impact factor: 10.005

6.  Src-inducible association of CrkL with procaspase-8 promotes cell migration.

Authors:  Ryon Graf; Simone Barbero; Nadine Keller; Lauren Chen; Sean Uryu; David Schlaepfer; Dwayne Stupack
Journal:  Cell Adh Migr       Date:  2013-06-10       Impact factor: 3.405

Review 7.  Novel roles of apoptotic caspases in tumor repopulation, epigenetic reprogramming, carcinogenesis, and beyond.

Authors:  Ruya Zhao; Rayan Kaakati; Andrew K Lee; Xinjian Liu; Fang Li; Chuan-Yuan Li
Journal:  Cancer Metastasis Rev       Date:  2018-09       Impact factor: 9.264

8.  Tumor-Associated Mutations in Caspase-6 Negatively Impact Catalytic Efficiency.

Authors:  Kevin B Dagbay; Maureen E Hill; Elizabeth Barrett; Jeanne A Hardy
Journal:  Biochemistry       Date:  2017-08-16       Impact factor: 3.162

9.  Caspase-8 mutations in head and neck cancer confer resistance to death receptor-mediated apoptosis and enhance migration, invasion, and tumor growth.

Authors:  Changyou Li; Ann Marie Egloff; Malabika Sen; Jennifer R Grandis; Daniel E Johnson
Journal:  Mol Oncol       Date:  2014-04-18       Impact factor: 6.603

Review 10.  Caspase-8 as a regulator of tumor cell motility.

Authors:  R P Graf; N Keller; S Barbero; D Stupack
Journal:  Curr Mol Med       Date:  2014-02       Impact factor: 2.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.